Cargando…
Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients
In the case of bladder cancer, carcinoma in situ (CIS) is known to have poor diagnosis. However, there are not enough studies that examine the biomarkers relevant to CIS development. Omics experiments generate data with tens of thousands of descriptive variables, e.g., gene expression levels. Often,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266725/ https://www.ncbi.nlm.nih.gov/pubmed/35806060 http://dx.doi.org/10.3390/ijms23137057 |